Testosterone replacement therapy and the risk of adverse cardiovascular outcomes and mortality

被引：0
|
作者：
Kevin M. Pantalone
Joyce George
Xinge Ji
Michael W. Kattan
Alex Milinovich
Janine M. Bauman
Bartolome Burguera
Robert S. Zimmerman
Anita D. Misra-Hebert
机构：
[1] Endocrinology and Metabolism Institute,Department of Endocrinology, Cleveland Clinic
[2] Southeast Georgia Health System,undefined
[3] Quantitative Health Sciences,undefined
[4] Cleveland Clinic,undefined
[5] Medicine Institute,undefined
[6] Cleveland Clinic,undefined
来源：
Basic and Clinical Andrology | / 29卷
关键词：
Testosterone replacement therapy; Male hypogonadism; Cardiovascular risk; Mortality;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] HORMONE REPLACEMENT THERAPY AND CARDIOVASCULAR RISK - THE CARDIOVASCULAR PHYSICIANS VIEWPOINT
    LIP, GYH
    BEEVERS, G
    ZARIFIS, J
    JOURNAL OF INTERNAL MEDICINE, 1995, 238 (05) : 389 - 399
  • [32] Testosterone deficiency and cardiovascular mortality
    Morgentaler, Abraham
    ASIAN JOURNAL OF ANDROLOGY, 2015, 17 (01) : 26 - 31
  • [33] Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
    A Barqawi
    E D Crawford
    International Journal of Impotence Research, 2006, 18 : 323 - 328
  • [34] Testosterone replacement therapy and the risk of stroke in men: A systematic review
    Loo, Simone Y.
    Chen, Bing Yu
    Yu, Oriana Hoi Yun
    Azoulay, Laurent
    Renoux, Christel
    MATURITAS, 2017, 106 : 31 - 37
  • [35] Identifying Survivors of Sepsis at Risk for Adverse Cardiovascular Outcomes
    Mayr, Florian B.
    Prescott, Hallie C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 204 (05) : 500 - 501
  • [36] Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
    Barqawi, A.
    Crawford, E. D.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2006, 18 (04) : 323 - 328
  • [37] Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin
    Evans, JMM
    Ogston, SA
    Emslie-Smith, A
    Morris, AD
    DIABETOLOGIA, 2006, 49 (05) : 930 - 936
  • [38] Testosterone replacement therapy is not associated with increased prostate cancer incidence, prostate cancer-specific, or cardiovascular disease-specific mortality in Finnish men
    Siltari, Aino
    Murtola, Teemu J.
    Kausz, Josefina
    Talala, Kirsi
    Taari, Kimmo
    Tammela, Teuvo L. J.
    Auvinen, Anssi
    ACTA ONCOLOGICA, 2023, 62 (12) : 1898 - 1904
  • [39] Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin
    J. M. M. Evans
    S. A. Ogston
    A. Emslie-Smith
    A. D. Morris
    Diabetologia, 2006, 49
  • [40] Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men
    C. Cattabiani
    S. Basaria
    G. P. Ceda
    M. Luci
    A. Vignali
    F. Lauretani
    G. Valenti
    R. Volpi
    M. Maggio
    Journal of Endocrinological Investigation, 2012, 35 : 104 - 120
12345